This is the first study to examine the potential utility of serial IP-10 measurements within a clinical decision support protocol aimed at improving oxygen delivery and controlling inflammation without compromising viral clearance or increasing susceptibility to secondary infections. This evidence concerns the gene CXCL10 and infection.